The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy.
Kertes
Peter J
PJ
University of Ottawa Eye Institute, Ottawa Hospital, General Campus, Ottawa, Ont. peter.kertes@sw.ca
Lee
Thomas K M
TK
Coupland
Stuart G
SG
D000368:Aged; D003676:Deferoxamine / Q000009:adverse effects*; D016903:Drug Monitoring; D004596:Electroretinography / Q000379:methods*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects*; D012160:Retina / Q000187:drug effects* / Q000473:pathology; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis*
D007502:Iron Chelating Agents; D003676:Deferoxamine